Patents by Inventor Tamar AUERBACH-NEVO

Tamar AUERBACH-NEVO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable pharmaceutical foam
    Patent number: 11938165
    Abstract: Provided are pharmaceutical foam compositions comprising a peptone, a peptide hydrolysate or an enzymatically-hydrolyzed protein prepared by enzymatic hydrolysis of a full-length protein; methods of preparation and uses thereof.
    Type: Grant
    Filed: August 18, 2021
    Date of Patent: March 26, 2024
    Assignees: Omrix Biopharmaceuticals Ltd., Ethicon, Inc.
    Inventors: Tamar Auerbach-Nevo, Ashley Deanglis, Israel Nur
  • Hemostatic composition comprising an anion exchanger and a calcium salt
    Patent number: 11857564
    Abstract: Provided are pharmaceutical compositions comprising an anion exchanger and a calcium salt; methods for inducing hemostasis at a site of bleeding by applying to the site of bleeding an effective amount of the compositions; and methods of preparation of the compositions.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: January 2, 2024
    Assignee: Omrix Biopharmaceuticals Ltd.
    Inventors: Tamar Auerbach-Nevo, Tali Negreanu-Gilboa, Hadas Alperin, Israel Nur
  • METHOD FOR PURIFYING AND QUANTIFYING THROMBIN AND ITS DEGRADATION POLYPEPTIDES
    Publication number: 20210403892
    Abstract: Provided is a method for purifying ?-thrombin and for quantifying ?-thrombin and its degradation polypeptides in a liquid proteinatious solution. The method employs a one-step anion exchange chromatography method. The method allows purification and/or quantification of a homogenous post-translationally modified ?-thrombin. The method can also be used for purification and/or quantification of ?-thrombin.
    Type: Application
    Filed: September 13, 2021
    Publication date: December 30, 2021
    Inventors: Tamar AUERBACH-NEVO, Nadav ORR, Israel NUR
  • STABLE PHARMACEUTICAL FOAM
    Publication number: 20210379140
    Abstract: Provided are pharmaceutical foam compositions comprising a peptone, a peptide hydrolysate or an enzymatically-hydrolyzed protein prepared by enzymatic hydrolysis of a full-length protein; methods of preparation and uses thereof.
    Type: Application
    Filed: August 18, 2021
    Publication date: December 9, 2021
    Inventors: Tamar AUERBACH-NEVO, Ashley DEANGLIS, Israel Nur
  • Method for purifying and quantifying thrombin and its degradation polypeptides
    Patent number: 11149263
    Abstract: Provided is a method for purifying ?-thrombin and for quantifying ?-thrombin and its degradation polypeptides in a liquid proteinatious solution. The method employs a one-step anion exchange chromatography method. The method allows purification and/or quantification of a homogenous post-translationally modified ?-thrombin. The method can also be used for purification and/or quantification of ?-thrombin.
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: October 19, 2021
    Assignee: Omrix Biopharmaceuticals Ltd.
    Inventors: Tamar Auerbach-Nevo, Nadav Orr, Israel Nur
  • Stable pharmaceutical foam
    Patent number: 11123397
    Abstract: Provided are pharmaceutical foam compositions comprising a peptone, a peptide hydrolysate or an enzymatically-hydrolyzed protein prepared by enzymatic hydrolysis of a full-length protein; methods of preparation and uses thereof.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: September 21, 2021
    Assignees: Omrix Biopharmaceuticals Ltd., Ethicon, Inc.
    Inventors: Tamar Auerbach-Nevo, Ashley Deanglis, Israel Nur
  • Method for purifying and quantifying thrombin and its degradation polypeptides
    Patent number: 11008560
    Abstract: Provided is a method for purifying ?-thrombin and for quantifying ?-thrombin and its degradation polypeptides in a liquid proteinatious solution. The method employs a one-step anion exchange chromatography method. The method allows purification and/or quantification of a homogenous post-translationally modified ?-thrombin. The method can also be used for purification and/or quantification of ?-thrombin.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: May 18, 2021
    Assignee: Omrix Biopharmaceuticals Ltd.
    Inventors: Tamar Auerbach-Nevo, Nadav Orr, Israel Nur
  • EXPANDABLE HEMOSTAT COMPOSED OF OXIDIZED CELLULOSE
    Publication number: 20210038757
    Abstract: An expandable biodegradable hemostatic matrix comprised of oxidized cellulose, and having a density ranging from about 0.8 to about 1.2 gr/cm3 is disclosed herein. The matrix may be expandable to at least 3 times its original volume within 4 sec upon contact with an aqueous solution room temperature. Further disclosed are methods for making the hemostatic matrix as well as method of treating a wound.
    Type: Application
    Filed: August 3, 2020
    Publication date: February 11, 2021
    Inventors: EREZ ILAN, OMRI FAINGOLD, TAMAR AUERBACH-NEVO, TALI NEGREANU-GILBOA, HADAS ALPERIN, Yi-Lan Allen Wang, Dwayne Looney
  • Plasma-supplemented formulation
    Patent number: 10806755
    Abstract: Provided herein is a plasma-supplemented fibrinogen and/or fibrin formulation, method for the preparation and use thereof.
    Type: Grant
    Filed: February 25, 2015
    Date of Patent: October 20, 2020
    Assignee: Omrix Biopharmaceuticals, Ltd.
    Inventors: Roberto Meidler, Elena Grimberg, Oleg Belyaev, Yonit Tiberman, Israel Nur, Tamar Auerbach-Nevo
  • METHOD FOR PURIFYING AND QUANTIFYING THROMBIN AND ITS DEGRADATION POLYPEPTIDES
    Publication number: 20200115694
    Abstract: Provided is a method for purifying ?-thrombin and for quantifying ?-thrombin and its degradation polypeptides in a liquid proteinatious solution. The method employs a one-step anion exchange chromatography method. The method allows purification and/or quantification of a homogenous post-translationally modified ?-thrombin. The method can also be used for purification and/or quantification of ?-thrombin.
    Type: Application
    Filed: December 12, 2019
    Publication date: April 16, 2020
    Inventors: Tamar AUERBACH-NEVO, Nadav ORR, Israel NUR
  • Method for purifying and quantifying thrombin and its degradation polypeptides
    Patent number: 10066224
    Abstract: Provided is a method for purifying ?-thrombin and for quantifying ?-thrombin and its degradation polypeptides in a liquid proteinatious solution. The method employs a one-step anion exchange chromatography method. The method allows purification and/or quantification of a homogenous post-translationally modified ?-thrombin. The method can also be used for purification and/or quantification of ?-thrombin.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: September 4, 2018
    Assignee: Omrix Biopharmaceuticals Ltd.
    Inventors: Tamar Auerbach-Nevo, Nadav Orr, Israel Nur
  • METHOD FOR PURIFYING AND QUANTIFYING THROMBIN AND ITS DEGRADATION POLYPEPTIDES
    Publication number: 20180201917
    Abstract: Provided is a method for purifying ?-thrombin and for quantifying ?-thrombin and its degradation polypeptides in a liquid proteinatious solution. The method employs a one-step anion exchange chromatography method. The method allows purification and/or quantification of a homogenous post-translationally modified ?-thrombin. The method can also be used for purification and/or quantification of ?-thrombin.
    Type: Application
    Filed: March 15, 2018
    Publication date: July 19, 2018
    Inventors: Tamar AUERBACH-NEVO, Nadav ORR, Israel NUR
  • HEMOSTATIC COMPOSITION COMPRISING AN ANION EXCHANGER AND A CALCIUM SALT
    Publication number: 20180177818
    Abstract: Provided are pharmaceutical compositions comprising an anion exchanger and a calcium salt; methods for inducing hemostasis at a site of bleeding by applying to the site of bleeding an effective amount of the compositions; and methods of preparation of the compositions.
    Type: Application
    Filed: December 13, 2017
    Publication date: June 28, 2018
    Inventors: TAMAR AUERBACH-NEVO, Tali NEGREANU-GILBOA, Hadas ALPERIN, Israel NUR
  • STABLE PHARMACEUTICAL FOAM
    Publication number: 20180071358
    Abstract: Provided are pharmaceutical foam compositions comprising a peptone, a peptide hydrolysate or an enzymatically-hydrolyzed protein prepared by enzymatic hydrolysis of a full-length protein; methods of preparation and uses thereof.
    Type: Application
    Filed: September 11, 2017
    Publication date: March 15, 2018
    Inventors: Tamar Auerbach-Nevo, Ashley DEANGLIS, Israel Nur
  • METHOD FOR PURIFYING AND QUANTIFYING THROMBIN AND ITS DEGRADATION POLYPEPTIDES
    Publication number: 20160244739
    Abstract: Provided is a method for purifying ?-thrombin and for quantifying ?-thrombin and its degradation polypeptides in a liquid proteinatious solution. The method employs a one-step anion exchange chromatography method. The method allows purification and/or quantification of a homogenous post-translationally modified ?-thrombin. The method can also be used for purification and/or quantification of ?-thrombin.
    Type: Application
    Filed: February 24, 2016
    Publication date: August 25, 2016
    Inventors: TAMAR AUERBACH-NEVO, NADAV ORR, ISRAEL NUR
  • PLASMA-SUPPLEMENTED FORMULATION
    Publication number: 20150238529
    Abstract: Provided herein is a plasma-supplemented fibrinogen and/or fibrin formulation, method for the preparation and use thereof.
    Type: Application
    Filed: February 25, 2015
    Publication date: August 27, 2015
    Inventors: Roberto MEIDLER, Elena GRIMBERG, Oleg BELYAEV, Yonit TIBERMAN, Israel NUR, Tamar AUERBACH-NEVO